# Levofloxacin, Chronic Bacterial Prostatitis

> **NCT00277511** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 120 (—)

## Conditions studied

- Prostatitis

## Interventions

- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT00277511
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 120 (—)
- **Last updated:** 2007-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00277511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00277511, "Levofloxacin, Chronic Bacterial Prostatitis". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00277511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*